Information Provided By:
Fly News Breaks for June 1, 2016
CRME
Jun 1, 2016 | 07:29 EDT
H.C. Wainwright analyst Swayampakula Ramakanth started Cardiome Pharma with a Buy rating and $9.50 price target.
News For CRME From the Last 2 Days
There are no results for your query CRME